Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
MYR | Fiscal Year Ending | | Latest |
(in millions) | Mar-15 | Mar-16 | Mar-17 | Mar-18 | Mar-19 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 230 | 155 | 268 | 186 | 144 | 178 | 88 | 139 | 222 | 296 | | 339 |
% Growth | NA | -32.7% | 73.2% | -30.6% | -22.4% | 23.4% | -50.5% | 57.1% | 59.9% | 33.5% | | |
| | | | | | | | | | | | |
Cost of Revenue | (171) | (117) | (199) | (102) | (72) | (101) | (48) | (85) | (151) | (208) | | (243) |
Gross Profit | 59 | 38 | 69 | 84 | 72 | 77 | 41 | 54 | 71 | 88 | | 96 |
% Revenue | 25.8% | 24.7% | 25.7% | 45.2% | 50.0% | 43.1% | 46.2% | 38.8% | 32.0% | 29.8% | | 28.3% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (18) | (16) | (17) | (17) | (17) | (20) | (19) | (23) | (30) | (30) | | (30) |
Other Inc / (Exp) | 491 | 90 | (8) | 26 | 43 | 21 | (37) | (10) | (6) | 5 | | 20 |
Total Operating Exp | 473 | 75 | (25) | 9 | 25 | 1 | (56) | (32) | (37) | (25) | | (10) |
| | | | | | | | | | | | |
Operating Income | 532 | 113 | 44 | 93 | 98 | 78 | (15) | 22 | 34 | 63 | | 86 |
% Revenue | 231.1% | 72.9% | 16.5% | 49.8% | 67.6% | 43.8% | -17.4% | 15.6% | 15.4% | 21.4% | | 25.4% |
| | | | | | | | | | | | |
Interest Expense | (3) | (25) | (30) | (24) | (23) | (25) | (18) | (26) | (20) | (24) | | (25) |
Pre-tax Income | 529 | 88 | 15 | 69 | 75 | 54 | (33) | (4) | 14 | 39 | | 61 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (152) | (14) | (6) | (21) | (22) | (5) | 3 | (0) | (11) | (13) | | (15) |
Net Income to Company | 377 | 74 | 9 | 48 | 53 | 48 | (31) | (5) | 3 | 26 | | 46 |
% Margin | 163.5% | 47.5% | 3.3% | 25.5% | 36.5% | 27.1% | -34.7% | -3.4% | 1.5% | 8.8% | | 13.7% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | (0) | 0 | 0 | 0 | 0 | 3 | (1) | | (1) |
Net Income to Stockholders | 377 | 74 | 9 | 47 | 53 | 48 | (30) | (4) | 6 | 25 | | 45 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 377 | 74 | 9 | 47 | 53 | 48 | (30) | (4) | 6 | 25 | | 45 |
% Margin | 163.5% | 47.5% | 3.3% | 25.5% | 36.5% | 27.1% | -34.4% | -3.1% | 2.7% | 8.4% | | 13.4% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.38 | 0.07 | 0.01 | 0.05 | 0.05 | 0.05 | (0.03) | (0.00) | 0.00 | 0.02 | | 0.03 |
Diluted EPS (Continuing Ops) | 0.38 | 0.07 | 0.01 | 0.03 | 0.04 | 0.03 | (0.03) | (0.00) | 0.00 | 0.02 | | 0.03 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 985.79 | 992.41 | 992.56 | 1,017.52 | 1,035.99 | 1,037.13 | 1,038.63 | 1,488.05 | 1,488.85 | 1,488.85 | | 1,488.85 |
WA Diluted Shares Out. | 998.12 | 994.40 | 992.56 | 1,474.41 | 1,487.71 | 1,488.85 | 1,038.63 | 1,488.05 | 1,488.85 | 1,488.85 | | 1,488.85 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 529 | 88 | 15 | 69 | 75 | 54 | (33) | (4) | 14 | 39 | | 61 |
Addback: Net Interest Expense | 3 | 25 | 30 | 24 | 23 | 25 | 18 | 26 | 20 | 24 | | 25 |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 4 | | 4 |
Addback: Depreciation & Amortization | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 4 | 5 | | 3 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | (0) | (0) | (0) | (2) | (0) | (1) | (7) | (1) | (0) | (1) | | (1) |
Addback: Gain (Loss) On Sale Of Assets | (0) | 0 | 0 | (0) | (1) | (0) | (0) | (0) | (0) | (0) | | (0) |
Addback: Asset Writedown | (519) | (107) | (9) | (35) | (46) | (3) | (6) | (2) | (13) | (22) | | (22) |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | (3) | 0 | (2) | (0) | 0 | | 0 |
Adjusted EBITDA | 15 | 8 | 37 | 58 | 54 | 74 | (27) | 19 | 29 | 51 | | 71 |
% Margin | 6.4% | 5.2% | 13.8% | 31.2% | 37.2% | 41.5% | -30.6% | 13.5% | 13.1% | 17.1% | | 21.0% |
| | | | | | | | | | | | |
Adjusted EBIT | 12 | 6 | 35 | 56 | 51 | 72 | (29) | 17 | 25 | 45 | | 68 |
% Margin | 5.4% | 3.7% | 12.9% | 29.9% | 35.1% | 40.2% | -32.5% | 12.3% | 11.3% | 15.4% | | 20.1% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 377 | 74 | 9 | 48 | 53 | 48 | (31) | (5) | 3 | 26 | | 46 |
Addback: Unusual Items | (520) | (107) | (10) | (37) | (47) | (6) | (13) | (5) | (13) | (22) | | (22) |
Less: Tax Benefit of Unusual Items (26%) | 135 | 28 | 2 | 10 | 12 | 2 | 3 | 1 | 3 | 6 | | 6 |
Adjusted Net Income | (8) | (6) | 2 | 20 | 18 | 43 | (40) | (8) | (7) | 9 | | 30 |
% Margin | -3.5% | -3.7% | 0.6% | 10.8% | 12.4% | 24.4% | -45.8% | -5.9% | -3.0% | 3.2% | | 8.8% |